Supplements in Cancer Care + Everyday Practice: What to Use, When, and Why / Oncology in Everyday Practice: Yes, You Can!
Supplements in Cancer Care + Everyday Practice: What to Use, When, and Why
Supplements come up in nearly every cancer conversation – and in plenty of everyday cases, too. This practical, evidence-informed session helps general practitioners confidently choose and use a short list of high-yield supplements in practice. We’ll focus on probiotics/synbiotics, sulforaphane, omega-3 fatty acids, and SAMe – when to reach for each, how to dose them, and what the research actually supports, including how to use them alongside common treatments. You’ll leave with practical dosing starting points, product selection tips, and real-world pearls you can use right away. You’ll see how these supplements fit into everyday cases across general practice, not just cancer care.
Learning Objectives:
- Review the integration of key supplements such as probiotics, omega-3 fatty acids, SAMe, and sulforaphane into both cancer-specific and general health treatment plans.
- Demonstrate the practical implementation of these supplements across a variety of clinical settings, ensuring safe and effective usage.
- Examine the latest research and clinical evidence supporting the use of these supplements, alongside traditional cancer therapies and their potential benefits beyond oncology.
- Optimize patient care strategies by incorporating supplements into comprehensive treatment protocols that improve outcomes and enhance quality of life.
Oncology in Everyday Practice: Yes, You Can!
Cancer cases can be challenging in general practice but with the right tools and a practical approach, many can be managed successfully in-house. In this case-based session, we’ll walk through real-world oncology scenarios GPs encounter regularly. From deciding which mast cell tumor cases are appropriate for Stelfonta® to managing canine lymphoma with Laverdia® when referral isn’t an option and exploring non-IV chemotherapy choices for feline lymphoma, this session offers actionable guidance for confident care. You’ll leave with tips you can implement immediately and the confidence to take on more oncology cases in your clinic.
Learning Objectives:
- Discuss treatment options for mast cell tumors in general practice, including when to consider surgery versus Stelfonta®, and how to decide which cases to manage in-clinic versus refer—especially when starting out with Stelfonta®.
- Compare oral chemotherapy options for canine lymphoma, including Laverdia® and lomustine, and identify practical strategies for treatment in general practice.
- Offer oral alternatives to intravenous chemotherapy for feline lymphoma cases when clients decline referral or traditional protocols.
Speaker: Sue Ettinger DVM, Diplomate ACVIM (Oncology)
Sue Ettinger, DVM, DACVIM (Oncology), widely recognized as Dr. Sue Cancer Vet®, brings over two decades of expertise in veterinary oncology to her position at Guardian Veterinary Specialists in Brewster, New York. She is among the 500 board-certified medical oncologists in North America. Her comprehensive training was completed at the Animal Medical Center in New York City.
Dr. Ettinger is not only a seasoned clinician but also a 2019 Western Veterinary Conference Small Animal Continuing Educator of the Year. She is a well-regarded speaker internationally, an author, and a staunch advocate for cancer awareness with her initiative, “See Something, Do Something, Why Wait? Aspirate.®”, aimed at promoting early detection of cancer.
On social media, Dr. Sue connects with a wide audience, including 55,000 followers on Instagram, 47,000 on Facebook, and 25,000 on YouTube, providing valuable information and support to pet owners and fellow veterinary professionals.
Beyond her professional life, Dr. Sue enjoys being a mother to two teenage boys and spending quality time with her energetic yellow Labrador, Penelope. An enthusiast of running and traveling, she finds joy in travel, especially to tropical beach destinations where she can unwind and recharge.
Sponsor:

